Evaluation the effect of vitamin D supplementation in patients with type I diabetes mellitus and vitamin D deficiency

Evaluation the effect of vitamin D supplementation on HbA1C in patients with type I diabetes mellitus and vitamin D deficiency

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2013070113822N1

Enrollment

Registered

2013-08-23

Start date

2013-04-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: diabetes (mellitus):type I. Condition 2: Vitamin D deficiency, unspecified. diabetes (mellitus):type I Vitamin D deficiency, unspecified

Interventions

for all patients with vitamin D deficiency,single dose of vitamin D(300,000 unit) will be injected intra muscular.Non-cooperative patients treated weekly with pearl vitamin D (50,000unit) orally for

Treatment - Drugs

Eligibility

Sex/Gender

All

Age

No minimum to 18 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: type I diabetic and vitamin D deficiency patients; normal liver function; normal renal function. exclusion criteria:Irregular use of calcium and vitamin D during the study; hypercalciuria with nephrolithiasis .

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
25OHD. Timepoint: before intervention,three mounths after intervention. Method of measurement: blood sampling, ng/dl.;HbA1C. Timepoint: before intervention,three mounths after intervention. Method of measurement: blood sampling.	—

Secondary

Measure	Time frame
Mg. Timepoint: before intervention. Method of measurement: blood sampling,Mg/dl.;P. Timepoint: before intervention. Method of measurement: bleeding sample/ Mg/dl.;Pth. Timepoint: before intervention. Method of measurement: ng/l.;Ca. Timepoint: before intervention. Method of measurement: blood sampling,Mg/dl.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Nasrin Fatahi

Golestan university of Medical Science

nfty3063@yahoo.com+98 17 1222 7720

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026